Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Samuelsson

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Internal Medicine|March 1, 1994
The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow-up of antihypertensive treatment in middle-aged men in the Primary Prevention Trial in Göteborg, SwedenO Samuelsson, T Hedner, B Persson, et al.
Mineral and Electrolyte Metabolism|January 1, 1992
Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failureP O Attman, C Knight-Gibson, M Tavella, et al.
European Journal of Clinical Pharmacology|January 1, 1992
A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertensionO Samuelsson, T Hedner, S Ljungman, et al.
Journal of Hypertension|April 1, 1993
Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study GroupS Agewall, B Persson, O Samuelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
The compositional abnormalities of lipoproteins in diabetic renal failureP O Attman, C Knight-Gibson, M Tavella, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2001
Do high-flux dialysis membranes affect renal dyslipidemia?P Ottosson, P O Attman, C Knight, et al.
Journal of Human Hypertension|April 1, 1994
Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, SwedenO Samuelsson, T Hedner, G Berglund, et al.
Journal of Internal Medicine|December 1, 1994
The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. Risk Factor Intervention Study GroupS Agewall, J Wikstrand, O Samuelsson, et al.
BMJ (Clinical Research Ed.)|April 11, 1992
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitorsT Hedner, O Samuelsson, H Lunde, et al.
PPAR Research|April 23, 2013
Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal DyslipidemiaO Samuelsson, P O Attman, I Gause-Nilsson, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Internal Medicine|March 1, 1994
The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow-up of antihypertensive treatment in middle-aged men in the Primary Prevention Trial in Göteborg, SwedenO Samuelsson, T Hedner, B Persson, et al.
Mineral and Electrolyte Metabolism|January 1, 1992
Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failureP O Attman, C Knight-Gibson, M Tavella, et al.
European Journal of Clinical Pharmacology|January 1, 1992
A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertensionO Samuelsson, T Hedner, S Ljungman, et al.
Journal of Hypertension|April 1, 1993
Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study GroupS Agewall, B Persson, O Samuelsson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1998
The compositional abnormalities of lipoproteins in diabetic renal failureP O Attman, C Knight-Gibson, M Tavella, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 26, 2001
Do high-flux dialysis membranes affect renal dyslipidemia?P Ottosson, P O Attman, C Knight, et al.
Journal of Human Hypertension|April 1, 1994
Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, SwedenO Samuelsson, T Hedner, G Berglund, et al.
Journal of Internal Medicine|December 1, 1994
The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. Risk Factor Intervention Study GroupS Agewall, J Wikstrand, O Samuelsson, et al.
BMJ (Clinical Research Ed.)|April 11, 1992
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitorsT Hedner, O Samuelsson, H Lunde, et al.
PPAR Research|April 23, 2013
Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal DyslipidemiaO Samuelsson, P O Attman, I Gause-Nilsson, et al.
Pageof 6